Regulatory Focus™ > News Articles > A Review of the Pharmacovigilance Programme of India

A Review of the Pharmacovigilance Programme of India

Posted 01 September 2011 | By

Over the past decade, India has been steadily evolving into one of the world's most important pharmaceutical centers for clinical trials and research and development. With success has come the burden of growing pressure on the Indian government to address concerns related to establishing a reliable drug safety framework.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe